Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 May;31(5):1011-6.
doi: 10.3892/ijmm.2013.1325. Epub 2013 Mar 28.

Expression and localisation of osteopontin and prominin-1 (CD133) in patients with endometriosis

Fabio D'Amico  1 , Evangelia Skarmoutsou, Giuseppe Quaderno, Grazia Malaponte, Carmelo La Corte, Giuseppe Scibilia, Gabriella D'Agate, Paolo Scollo, Filippo Fraggetta, Demetrios A Spandidos, Maria Clorinda Mazzarino
Affiliations

Expression and localisation of osteopontin and prominin-1 (CD133) in patients with endometriosis

Fabio D'Amico et al. Int J Mol Med. 2013 May.

Abstract

In this study, we investigated the expression and localisation of the proteins, osteopontin (OPN) and prominin-1 (CD133), as well as the plasma OPN levels in the endometrium of patients with endometriosis. Samples of ectopic endometriotic lesions and normal endometrium were obtained from 31 women with endometriosis and 28 healthy control subjects. The mRNA and protein expression of OPN and CD133 was analysed by real‑time RT-PCR and immunohistochemistry. The plasma levels of OPN were determined by ELISA. Our results revealed that OPN mRNA and protein expression, as well as its release in the blood, was significantly increased in the endometriotic lesions in comparison to normal tissue. Although the presence of CD133+ cells was detected in the normal endometrium, as well as in the endometriosis specimens, a significant quantitative variation of this protein was not demonstrated in the patients with endometriosis. In conclusion, our data indicate that OPN is involved in the development of endometriosis by enhancing the invasiveness, proliferation and survival of endometrial cells in ectopic lesions. CD133 cannot be used as a disease marker for endometriosis, although an involvement of this protein in the pathogenesis of endometriosis cannot be excluded.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Real-time RT-PCR analysis of osteopontin (OPN) and CD133 mRNA expression in the ectopic (endometriotic) and eutopic (control) endometrium. (A) OPN mRNA expression was significantly higher in patients with endometriosis in comparison to the control subjects. (B) Although CD133 expression was slightly higher in the patients with endometriosis in comparison to the control subjects, the difference was not statistically significant (*p<0.01).
Figure 2
Figure 2
Plasma osteopontin levels in women with endometriosis and control subjects. The mean plasma osteopontin levels were higher in the patients with endometriosis compared to the control group (*p<0.01).
Figure 3
Figure 3
Representative micrographs of immunohistochemistry of osteopontin (OPN) and CD133 expression in the eutopic normal endometrium and endometriotic lesions. (a) In normal tissue, OPN was exclusively immunolocalised in the cytoplasm of epithelium of the functional layer. (b) In endometriotic tissue (stage III-IV), OPN expression was higher in comparison to the control samples, and its localisation was restricted to the cytoplasm of epithelial gland cells, as well as to the macrophages in the stroma. (c) In the control tissue, the surface of epithelial cells lining the lumen was immunostained for CD133. (d) The immunohistochemical pattern for CD133 in endometriotic tissue (stage III-IV) was similar to that obtained in control tissue (bars: a, 80; b, 80; c, 90; and d, 80 μm).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. de Ziegler D, Borghese B, Chapron C. Endometriosis and infertility: pathophysiology and management. Lancet. 2012;376:730–738. - PubMed
    1. Swiersz LM. Role of endometriosis in cancer and tumor development. Ann NY Acad Sci. 2002;955:281–292. - PubMed
    1. Borghese B, Mondon F, Noël JC, Fayt I, Mignot TM, Vaiman D, Chapron C. Gene expression profile for ectopic versus eutopic endometrium provides new insights into endometriosis oncogenic potential. Mol Endocrinol. 2008;22:2557–2562. - PubMed
    1. Anborgh PH, Mutrie JC, Tuck AB, Chambers AF. Role of the metastasis-promoting protein osteopontin in the tumour microenvironment. J Cell Mol Med. 2010;14:2037–2044. - PMC - PubMed
    1. Liaw L, Skinner MP, Raines EW, Ross R, Cheresh DA, Schwartz SM, Giachelli CM. The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. Role of alpha v beta 3 in smooth muscle cell migration to osteopontin in vitro. J Clin Invest. 1995;95:713–724. - PMC - PubMed

MeSH terms